Suppr超能文献

18F和125I标记的抗Tac二硫键稳定Fv片段在白细胞介素2α受体阳性肿瘤异种移植裸鼠体内的生物分布。

Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.

作者信息

Choi C W, Lang L, Lee J T, Webber K O, Yoo T M, Chang H K, Le N, Jagoda E, Paik C H, Pastan I

机构信息

Department of Nuclear Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1180, USA.

出版信息

Cancer Res. 1995 Nov 15;55(22):5323-9.

PMID:7585595
Abstract

We evaluated the biodistribution, pharmacokinetics, and generation of catabolites of an 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragment (dsFv) in tumor-bearing nude mice. This dsFv is genetically engineered from a murine monoclonal antibody that recognizes the alpha subunit of the interleukin 2 (IL-2 alpha) receptor. Labeling was performed with 18F using N-succinimidyl 4-([18F]fluoromethyl)benzoate or with 125I using the Iodo-Gen method. The immunoreactivities of the radiolabeled anti-Tac dsFv were > 82%. The biodistribution was evaluated (at 15, 45, and 90 min and 6 h) in athymic nude mice (approximately five/group) bearing s.c. tumor xenografts. Cell line A431 served as the IL-2 receptor-negative control tumor, whereas the ATAC4 cell line served as our IL-2 receptor-positive tumor. Animals received injections of 18F-labeled anti-Tac dsFv (0.7-1.4 megabecquerels/1.5-3 micrograms) and 125I-labeled anti-Tac dsFv (0.1-0.4 megabecquerels/0.9-1 microgram). Blood clearance for both preparations was rapid, with < 10% retained in the blood by 15 min. Maximum accumulation in ATAC4 tumors occurred between 45 and 90 min and peaked at a mean of 4.2% injected dose/g (18F) and 5.6% of injected dose/g (125I). At 6 h, the ATAC4 tumors contained 11 times more 18F and 3 times more 125I than did the A431 tumors. The ATAC4 tumor:blood ratios for the 18F and 125I were > 12:1 and > 1.4:1 at 6 h, respectively, whereas the ratios for the antigen-negative A431 tumor were less than 1. The kidneys were the major route of elimination. Catabolites appeared quickly and were identified as [125I]iodide and predominantly N-epsilon-[18F]4-fluoromethylbenzoyl(alpha-N-acetyl) lysine. This is the first study to evaluate the biodistribution of an 18F-labeled Fv fragment in vitro and in vivo. In vivo, the dsFv was taken up rapidly by the kidneys, producing lysine-containing catabolites for 18F-labeled dsFv and [125I]iodide for 125I-labeled dsFv.

摘要

我们评估了18F和125I标记的抗Tac二硫键稳定化Fv片段(dsFv)在荷瘤裸鼠体内的生物分布、药代动力学及代谢产物的生成情况。该dsFv是由一种识别白细胞介素2(IL-2α)受体α亚基的鼠单克隆抗体制备而来的基因工程产物。采用N-琥珀酰亚胺基4-([18F]氟甲基)苯甲酸酯用18F进行标记,或采用碘代聚苯乙烯法用125I进行标记。放射性标记的抗Tac dsFv的免疫反应性>82%。在携带皮下肿瘤异种移植的无胸腺裸鼠(每组约5只)中评估了生物分布(在15、45、90分钟和6小时时)。细胞系A431用作IL-2受体阴性对照肿瘤,而ATAC4细胞系用作我们的IL-2受体阳性肿瘤。动物接受注射18F标记的抗Tac dsFv(0.7 - 1.4兆贝克勒尔/1.5 - 3微克)和125I标记的抗Tac dsFv(0.1 - 0.4兆贝克勒尔/0.9 - 1微克)。两种制剂的血液清除都很快,到15分钟时血液中保留的量<10%。ATAC4肿瘤中的最大蓄积发生在45至90分钟之间,峰值分别为注射剂量/克的4.2%(18F)和5.6%(125I)。在6小时时,ATAC4肿瘤中含有的18F比A431肿瘤多11倍,含有的125I比A431肿瘤多3倍。18F和125I在6小时时的ATAC4肿瘤与血液的比值分别>12:1和>1.4:1,而抗原阴性的A431肿瘤的比值小于1。肾脏是主要的清除途径。代谢产物很快出现,鉴定为[125I]碘化物,对于18F标记的dsFv主要是N-ε-[18F]4-氟甲基苯甲酰(α-N-乙酰)赖氨酸。这是第一项在体外和体内评估18F标记的Fv片段生物分布的研究。在体内,dsFv被肾脏迅速摄取,对于18F标记的dsFv产生含赖氨酸代谢产物,对于125I标记的dsFv产生[125I]碘化物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验